{
  "id": 12622484,
  "name": "HELSINN HEALTCARE S.A., petitioner, v. TEVA PHARMACEUTICALS USA, INC., et al.",
  "name_abbreviation": "Helsinn Healtcare S.A. v. Teva Pharm. USA, Inc.",
  "decision_date": "2018-10-09",
  "docket_number": "No. 17\u20131229.",
  "first_page": "358",
  "last_page": "358",
  "citations": [
    {
      "type": "official",
      "cite": "139 S. Ct. 358"
    },
    {
      "type": "parallel",
      "cite": "202 L. Ed. 2d 216"
    }
  ],
  "court": {
    "name_abbreviation": "U.S.",
    "id": 9009,
    "name": "Supreme Court of the United States"
  },
  "jurisdiction": {
    "id": 39,
    "name_long": "United States",
    "name": "U.S."
  },
  "cites_to": [],
  "analysis": {
    "cardinality": 38,
    "char_count": 266,
    "sha256": "4380034f6a0f503bf0015cb51981ebf314b9a108dee446a0e558e1cbd032bece",
    "simhash": "1:f2a4101487e4c614",
    "word_count": 42
  },
  "last_updated": "2021-09-08T21:16:17.237805+00:00",
  "provenance": {
    "date_added": "2021-08-27",
    "source": "Fastcase",
    "batch": "2021"
  },
  "casebody": {
    "judges": [],
    "parties": [
      "HELSINN HEALTCARE S.A., petitioner,\nv.\nTEVA PHARMACEUTICALS USA, INC., et al."
    ],
    "opinions": [
      {
        "text": "",
        "type": "majority",
        "author": null
      }
    ],
    "attorneys": [
      "Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument granted."
    ],
    "corrections": "",
    "head_matter": "HELSINN HEALTCARE S.A., petitioner,\nv.\nTEVA PHARMACEUTICALS USA, INC., et al.\nNo. 17-1229.\nSupreme Court of the United States\nOct. 9, 2018.\nMotion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument granted."
  },
  "file_name": "0358-02",
  "first_page_order": 358,
  "last_page_order": 358
}
